Overview:
Nutritional supplements play an important role in the early
management of age-related macular degeneration (AMD). Supplements containing antioxidants
and macular pigments have been shown to slow AMD progression, and emerging data
indicate a protective role for B vitamins. This program will focus on key data related
to nutritional supplementation as a treatment strategy for early AMD.
Learning Objectives:
Upon
completion of this activity, participants will be able to:
- Summarize the classification of age-related macular degeneration (AMD) based on staging
- Outline the design and major findings from the AREDS and AREDS2 clinical trials, including the 10-year follow-on study
- Explain the role of specific B vitamins in the treatment of patients with neovascular AMD when used alongside AREDS2 formulations
- Integrate findings from AREDS and AREDS2 clinical trials and emerging evidence on B vitamin supplementation in treatment recommendations for patients with AMD
Target Audience:
This educational activity is directed toward optometrists
and other eyecare professionals involved in the management of patients with
retinal disease.

Jeffry D. Gerson, OD, FAAO

Cecelia Koetting, OD, FAAO, DipABO

Daniel Epshtein, OD
Physicians’ Education Resource®, LLC, is accredited by COPE to provide continuing education to optometrists.
Physicians’ Education Resource®, LLC, designates this activity for a maximum of 1.0 COPE credit.



